Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease

Thyroid

Volumn 15, Issue 10, 2005, Pages 1119-1124

  Kurylowicz, Alina ^a   Kula, Dorota ^b   Ploski, Rafal ^c   Skorka, Agata ^c   Jurecka Lubieniecka, Beata ^b   Zebracka, Jadwiga ^b   Steinhof Radwanska, Katarzyna ^b   Hasse Lazar, Kornelia ^b   Hiromatsu, Yuji ^d   Jarzab, Barbara ^b   Bednarczuk, Tomasz ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 22; RADIOACTIVE IODINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE DURATION; ENDOCRINE OPHTHALMOPATHY; FAMILY HISTORY; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GRAVES DISEASE; HUMAN; ISRAEL; ITALY; KOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLAND; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS; THYROIDECTOMY; UNITED KINGDOM; UNITED STATES;

ADULT; ANTIGENS, CD40; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; MALE; PHENOTYPE; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 28344431684     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1119     Document Type: Article

References (40)

1. Stamenkovic I, Clark EA, Seed B 1989 A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403-1410.
2. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J 1994 Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272.
3. Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, Phipps RP 1997 Human thyroid fibroblasts exhibit a distinctive phenotype in culture: Characteristic ganglioside profile and functional CD40 expression. Endocrinology 138:5576-5588.
4. Metcalfe RA, McIntosh RC, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP 1998 Detection of CD40 on human thyroid follicular cells: Analysis of expression and function. J Clin Endocrinol Metab 83:1268-1274.
5. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A 1992 The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J 11:4313-4321.
6. Carayanniotis G, Masters SR, Noelle RJ 1997 Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426.
7. Boon L, Brok HP, Bauer J, Ortiz-Buijsse A, Schellekens MM, Ramdien-Murli S, Blezer E, van Meurs M, Ceuppens J, de Boer M, 't Hart BA, Laman JD 2001 Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 167:2942-2949.
8. Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC 2001 Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. J Immunol 166:6893-6898.
9. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H 2001 Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development. J Immunol 166:353-360.
10. Amrani A, Serra P, Yamanouchi J, Han B, Thiessen S, Verdaguer J, Santamaria P 2002 CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells. Immunity 16:719-732.
11. Cao HJ, Wang HS, Zhang Y, Lin H-Y, Phipps RP, Smith TJ 1998 Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 273:29615-29625.
12. Lougaris V, Badolato R, Ferrari S, Plebani A 2005 Hyper immunoglobulin M syndrome due to CD40 deficiency: Clinical, molecular, and immunological features. Immunol Rev 203:48-66.
13. Tomer Y, Concepcion E, Greenberg DA 2002 A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129-1135.
14. Jacobson EM, Concepcion E, Oashi T, Tomer Y.A 2005 Graves' disease associated Kozak sequence SNP enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 146:2684-2691.
15. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, J Park J 2003 A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13:919-925.
16. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC 2004 A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 61:269-272.
17. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH 2004 Role of the CD40 locus in Graves' disease. Thyroid 14:506-509.
18. Tomer Y, Davies TF, Greenberg DA 2005 What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol (Oxf) 62:258.
19. Simmonds MJ, Gough SC 2005 Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 71:93-113.
20. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 24:694-717.
21. Vaidya B, Kendall-Taylor P, Pearce SH 2002 The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 87:5385-5397.
22. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J 2003 Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol 148:13-18.
23. Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J 2004 Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles wuh u caves' ophthalmopathy. Hum Immunol 65:632-639.
24. th Annual Meeting of the European Thyroid Association, September, 2004 Istanbul, Turkey. Poster No 135, Abstract No: 40.
25. Skorka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R 2005 Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 62:679-682.
26. Mantel N, Haenszel W 1959 Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
27. Badenhoop K, Boehm BO 2004 Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp Clin Endocrinol Diabetes 112:407-415.
28. Weetman AP 2003 Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol 148:1-9.
29. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Hewlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 6939:506-511.
30. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH 2004 The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab. 89:5862-5865.
31. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC 2005 Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76:157-163.
32. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Ranee HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B. Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA 2004 Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
33. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF 1998 A new Graves' disease-susceptibility locus maps to the chromosome 20q11.2. Am J Hum Genet 63:1749-1756.
34. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF 2003 Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736-747.
35. Pearce SHS, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves' disease. Am J Hum Genet 65:1462-1465.
36. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste C, Stevens H, Carr P, Nutland S, McKinney P, Shield JP, Wang W, Cordell HJ, Walker N, Todd JA, Concannon P 2002 Parameters for reliable results in genetic association studies in common disease. Nat Genet 30:149-150.
37. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182.
38. Munafo MR, Flint J 2004 Meta-analysis of genetic association studies. Trends Genet 20:439-444.
39. Salanti G, Sanderson S, Higgins JP 2005 Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7:13-20.
40. Hegedius L, Brix TH, Vestergaard P 2004 Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 27:265-271.